Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1989 Oct 1;170(4):1103–1115. doi: 10.1084/jem.170.4.1103

Expansion of natural killer cells but not T cells in human interleukin 2/interleukin 2 receptor (Tac) transgenic mice

PMCID: PMC2189472  PMID: 2571665

Abstract

Transgenic mice expressing both human IL-2 and the L chain of IL-2-R constitutively had an unusual expansion of Thy-1+/CD3-4-8- large granular lymphocytes, which bore the elevated NK activity. Unexpectedly, the transgenic mice had neither T cell expansion nor autoreactive antibodies. The increase in number and activity of NK cells seems to be responsible for both the severe interstitial pneumonia and lymphocyte depletion in the spleen that we found in these transgenic mice. In addition, we found the selective loss of Purkinje cells in the cerebellum of the mice, which gave rise to their disturbed gait. All the transgenic mice died by 4 wk of age.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benveniste E. N., Merrill J. E. Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature. 1986 Jun 5;321(6070):610–613. doi: 10.1038/321610a0. [DOI] [PubMed] [Google Scholar]
  2. Clevers H., Alarcon B., Wileman T., Terhorst C. The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol. 1988;6:629–662. doi: 10.1146/annurev.iy.06.040188.003213. [DOI] [PubMed] [Google Scholar]
  3. Depper J. M., Leonard W. J., Krönke M., Waldmann T. A., Greene W. C. Augmented T cell growth factor receptor expression in HTLV-1-infected human leukemic T cells. J Immunol. 1984 Oct;133(4):1691–1695. [PubMed] [Google Scholar]
  4. Gately M. K., Anderson T. D., Hayes T. J. Role of asialo-GM1-positive lymphoid cells in mediating the toxic effects of recombinant IL-2 in mice. J Immunol. 1988 Jul 1;141(1):189–200. [PubMed] [Google Scholar]
  5. Hansson M., Kiessling R., Andersson B., Kärre K., Roder J. NK cell-sensitive T-cell subpopulation in thymus: inverse correlation to host NK activity. Nature. 1979 Mar 8;278(5700):174–176. doi: 10.1038/278174a0. [DOI] [PubMed] [Google Scholar]
  6. Hattori M., Sudo T., Izawa H., Kano S., Minato N. Developmental regulation of the extrathymic differentiation potential of the progenitor cells for T cell lineage. Int Immunol. 1989;1(2):151–159. doi: 10.1093/intimm/1.2.151. [DOI] [PubMed] [Google Scholar]
  7. Herberman R. B., Reynolds C. W., Ortaldo J. R. Mechanism of cytotoxicity by natural killer (NK) cells. Annu Rev Immunol. 1986;4:651–680. doi: 10.1146/annurev.iy.04.040186.003251. [DOI] [PubMed] [Google Scholar]
  8. Hercend T., Schmidt R. E. Characteristics and uses of natural killer cells. Immunol Today. 1988 Oct;9(10):291–293. doi: 10.1016/0167-5699(88)91317-5. [DOI] [PubMed] [Google Scholar]
  9. Ishida Y., Nishi M., Taguchi O., Inaba K., Minato N., Kawaichi M., Honjo T. Effects of the deregulated expression of human interleukin-2 in transgenic mice. Int Immunol. 1989;1(2):113–120. doi: 10.1093/intimm/1.2.113. [DOI] [PubMed] [Google Scholar]
  10. Jenkinson E. J., Kingston R., Owen J. J. Importance of IL-2 receptors in intra-thymic generation of cells expressing T-cell receptors. Nature. 1987 Sep 10;329(6135):160–162. doi: 10.1038/329160a0. [DOI] [PubMed] [Google Scholar]
  11. Leo O., Foo M., Sachs D. H., Samelson L. E., Bluestone J. A. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1374–1378. doi: 10.1073/pnas.84.5.1374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lotze M. T., Chang A. E., Seipp C. A., Simpson C., Vetto J. T., Rosenberg S. A. High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings. JAMA. 1986 Dec 12;256(22):3117–3124. [PubMed] [Google Scholar]
  13. Maeda M., Arima N., Daitoku Y., Kashihara M., Okamoto H., Uchiyama T., Shirono K., Matsuoka M., Hattori T., Takatsuki K. Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. Blood. 1987 Nov;70(5):1407–1411. [PubMed] [Google Scholar]
  14. Malek T. R., Robb R. J., Shevach E. M. Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5694–5698. doi: 10.1073/pnas.80.18.5694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Merrill J. E., Kutsunai S., Mohlstrom C., Hofman F., Groopman J., Golde D. W. Proliferation of astroglia and oligodendroglia in response to human T cell-derived factors. Science. 1984 Jun 29;224(4656):1428–1430. doi: 10.1126/science.6610212. [DOI] [PubMed] [Google Scholar]
  16. Nishi M., Ishida Y., Honjo T. Expression of functional interleukin-2 receptors in human light chain/Tac transgenic mice. Nature. 1988 Jan 21;331(6153):267–269. doi: 10.1038/331267a0. [DOI] [PubMed] [Google Scholar]
  17. Sharon M., Siegel J. P., Tosato G., Yodoi J., Gerrard T. L., Leonard W. J. The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells. J Exp Med. 1988 Mar 1;167(3):1265–1270. doi: 10.1084/jem.167.3.1265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Smith K. A. Interleukin-2: inception, impact, and implications. Science. 1988 May 27;240(4856):1169–1176. doi: 10.1126/science.3131876. [DOI] [PubMed] [Google Scholar]
  19. Springer T., Galfré G., Secher D. S., Milstein C. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol. 1979 Apr;9(4):301–306. doi: 10.1002/eji.1830090410. [DOI] [PubMed] [Google Scholar]
  20. Tentori L., Longo D. L., Zuñiga-Pflucker J. C., Wing C., Kruisbeek A. M. Essential role of the interleukin 2-interleukin 2 receptor pathway in thymocyte maturation in vivo. J Exp Med. 1988 Nov 1;168(5):1741–1747. doi: 10.1084/jem.168.5.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tsudo M., Goldman C. K., Bongiovanni K. F., Chan W. C., Winton E. F., Yagita M., Grimm E. A., Waldmann T. A. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5394–5398. doi: 10.1073/pnas.84.15.5394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tsudo M., Kitamura F., Miyasaka M. Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies. Proc Natl Acad Sci U S A. 1989 Mar;86(6):1982–1986. doi: 10.1073/pnas.86.6.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Uchiyama T., Broder S., Waldmann T. A. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol. 1981 Apr;126(4):1393–1397. [PubMed] [Google Scholar]
  24. Waldmann T. A. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science. 1986 May 9;232(4751):727–732. doi: 10.1126/science.3008337. [DOI] [PubMed] [Google Scholar]
  25. Wang H. M., Smith K. A. The interleukin 2 receptor. Functional consequences of its bimolecular structure. J Exp Med. 1987 Oct 1;166(4):1055–1069. doi: 10.1084/jem.166.4.1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Yodoi J., Uchiyama T., Maeda M. T-cell growth factor receptor in adult T-cell leukemia. Blood. 1983 Aug;62(2):509–511. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES